DK0483077T3 - Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer - Google Patents

Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer

Info

Publication number
DK0483077T3
DK0483077T3 DK91830402.3T DK91830402T DK0483077T3 DK 0483077 T3 DK0483077 T3 DK 0483077T3 DK 91830402 T DK91830402 T DK 91830402T DK 0483077 T3 DK0483077 T3 DK 0483077T3
Authority
DK
Denmark
Prior art keywords
dose
bromomelatonin
iodomelatonin
per day
drug
Prior art date
Application number
DK91830402.3T
Other languages
English (en)
Inventor
Franco Fraschini
Ermanno Duranti
Bella Luigi Di
Bojidar Stankov
Aldo Laguzzi
Original Assignee
I F L O S A S Di Giorgio E Ald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT02159690A external-priority patent/IT1243978B/it
Priority claimed from IT2233890A external-priority patent/IT1251743B/it
Priority claimed from ITMI912438A external-priority patent/IT1251204B/it
Application filed by I F L O S A S Di Giorgio E Ald filed Critical I F L O S A S Di Giorgio E Ald
Application granted granted Critical
Publication of DK0483077T3 publication Critical patent/DK0483077T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DK91830402.3T 1990-09-28 1991-09-27 Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer DK0483077T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT02159690A IT1243978B (it) 1990-09-28 1990-09-28 Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.
IT2233890A IT1251743B (it) 1990-12-11 1990-12-11 Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva e terapeutica, nei tumori del seno, dell'utero e nel melanoma, ad azione anticinetosica a base di agonisti della melatonina ad alta affinita', in associazione con un progestinico
ITMI912438A IT1251204B (it) 1991-09-16 1991-09-16 Farmaco per uso umano, ad azione contraccettiva e regolatrice del ciclo mestruale, ad azione oncostatica preventiva e terapeutica, nei tumori mammari e nel melanoma, e ad azione anticinetosica e metodo di sintesi

Publications (1)

Publication Number Publication Date
DK0483077T3 true DK0483077T3 (da) 1996-04-15

Family

ID=27273202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91830402.3T DK0483077T3 (da) 1990-09-28 1991-09-27 Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer

Country Status (8)

Country Link
US (1) US5272141A (da)
EP (2) EP0641565B1 (da)
JP (1) JP2849692B2 (da)
AT (2) ATE131058T1 (da)
DE (2) DE69115221T2 (da)
DK (1) DK0483077T3 (da)
ES (1) ES2082959T3 (da)
GR (1) GR3019175T3 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
AU2109695A (en) 1994-03-30 1995-10-23 Novartis Ag Screening method using the rzr receptor family
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
WO2005084664A1 (ja) * 2004-03-08 2005-09-15 Kanazawa University Technology Licensing Organization Ltd. インドール誘導体及びその用途
JP3964417B2 (ja) * 2004-09-27 2007-08-22 国立大学法人金沢大学 インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
CN113480467B (zh) * 2021-07-13 2022-12-30 河北维达康生物科技有限公司 一种放射性示踪剂2-碘褪黑素的合成工艺
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
JPS5686130A (en) * 1979-12-18 1981-07-13 Nissan Chem Ind Ltd Alpha-halo m-benzoylphenyl acetic acid derivative
JPS6033820A (ja) * 1983-08-05 1985-02-21 Nippon Steel Corp 加熱手段を備えた熱間鋼材蓄積装置
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
JPS6256475A (ja) * 1985-09-05 1987-03-12 Daicel Chem Ind Ltd ５−ハロピリジン−３−カルボキサミド化合物
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
DE69115221D1 (de) 1996-01-18
EP0641565B1 (en) 2000-03-15
ATE190490T1 (de) 2000-04-15
US5272141A (en) 1993-12-21
JPH06263635A (ja) 1994-09-20
EP0483077B1 (en) 1995-12-06
DE69115221T2 (de) 1996-08-22
ES2082959T3 (es) 1996-04-01
EP0483077A3 (en) 1992-09-23
ATE131058T1 (de) 1995-12-15
EP0641565A1 (en) 1995-03-08
JP2849692B2 (ja) 1999-01-20
GR3019175T3 (en) 1996-06-30
EP0483077A2 (en) 1992-04-29
DE69132061D1 (de) 2000-04-20

Similar Documents

Publication Publication Date Title
DK0483077T3 (da) Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
NO306377B1 (no) Doseform for avgivelse av et medikament
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
PT90049A (pt) Forma de dosagem para administrar um medicamento para terapia humana
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
EA200300544A1 (ru) Эффективные противоопухолевые лекарственные средства
DE69202441T2 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
NO932570D0 (no) Behandling av neoplastisk sykdom med interleukin-10
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
KR890000108A (ko) 종양 치료용 약제학적 조성물
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
KR927002224A (ko) 항종양효과증강제 및 항종양제
PT75533B (fr) Procede de preparation de derives de phenoxy-3 propanol-2 et de compositions pharmaceutiques les contenant
FR2392668A1 (fr) Medicament a base de coproporphyrine
IT1251204B (it) Farmaco per uso umano, ad azione contraccettiva e regolatrice del ciclo mestruale, ad azione oncostatica preventiva e terapeutica, nei tumori mammari e nel melanoma, e ad azione anticinetosica e metodo di sintesi
IL90059A0 (en) Paromomycin or its derivatives or salts thereof for treatment of human parasitic diseases
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
FR2635006B1 (fr) Medicament destine a regulariser les secretions hormonales et a traiter la sterilite
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare